The news of Lake Street analyst maintaining a Buy rating on Biolase is positive for the stock. However, the lowering of the price target from $1.5 to $0.4 indicates a reduced growth potential, which may offset the positive sentiment. Therefore, the short-term impact on the stock price is expected to be neutral.